valve replacement surgery），若病人難以承受開放手術風險，則一般採用經皮主動脈瓣置換術（TAVR）。目前市面上的人工瓣膜主要有機械式瓣膜（英语：mechanical heart valve）與生物性瓣膜（英语：bioprosthetic heart valve ...

Patients who receive a mechanical heart valve require lifelong anticoagulant ... for just 3-6 months after bioprosthetic valve replacement, even for patients in sinus rhythm.

Japan), who presented the late-breaking findings today at the American Heart Association 2024 Scientific Sessions. “The availability of edoxaban could offer more flexibility in anticoagulant treatment ...

People who receive a mechanical heart valve require lifelong anticoagulant therapy to prevent thrombus (blood clot) formation on the valve. Patients who receive a bioprosthetic (made with human or ...

People who receive a mechanical heart valve require lifelong anticoagulant therapy to prevent thrombus (blood clot) formation on the valve. Patients who receive a bioprosthetic (made with human or ...

People who receive a mechanical heart valve require lifelong anticoagulant therapy to prevent thrombus (blood clot) formation on the valve. Patients who receive a bioprosthetic (made with human or ...

The randomized, multi-center trial out of Japan randomized approximately 400 adults who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position to receive either ...